$IVOB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INVO Bioscience, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INVO Bioscience, Inc.. Get notifications about new insider transactions in INVO Bioscience, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | IVOB | INVO Bioscience, I ... | Messina Rebecca | Director | Option Exercise | A | 3.67 | 6,239 | 22,897 | 6,239 | |
May 13 2021 | IVOB | INVO Bioscience, I ... | Messina Rebecca | Director | Grant | A | 0.00 | 4,806 | 0 | 4,806 | 0 to 4.8 K |
May 11 2021 | IVOB | INVO Bioscience, I ... | AWM Investment Company, Inc. | 10% Owner | Buy | P | 3.85 | 1,000 | 3,848 | 1,158,075 | 1.2 M to 1.2 M (+0.09 %) |
May 11 2021 | IVOB | INVO Bioscience, I ... | AWM Investment Company, Inc. | 10% Owner | Buy | P | 3.85 | 2,457 | 9,459 | 1,157,075 | 1.2 M to 1.2 M (+0.21 %) |
May 11 2021 | IVOB | INVO Bioscience, I ... | AWM Investment Company, Inc. | 10% Owner | Buy | P | 3.85 | 465 | 1,790 | 1,154,618 | 1.2 M to 1.2 M (+0.04 %) |
May 11 2021 | IVOB | INVO Bioscience, I ... | AWM Investment Company, Inc. | 10% Owner | Buy | P | 4.44 | 3,800 | 16,870 | 1,154,153 | 1.2 M to 1.2 M (+0.33 %) |
May 11 2021 | IVOB | INVO Bioscience, I ... | AWM Investment Company, Inc. | 10% Owner | Buy | P | 3.90 | 3,500 | 13,647 | 1,150,353 | 1.1 M to 1.2 M (+0.31 %) |
May 11 2021 | IVOB | INVO Bioscience, I ... | AWM Investment Company, Inc. | 10% Owner | Buy | P | 3.64 | 5,801 | 21,110 | 1,146,853 | 1.1 M to 1.1 M (+0.51 %) |
May 11 2021 | IVOB | INVO Bioscience, I ... | AWM Investment Company, Inc. | 10% Owner | Buy | P | 3.83 | 9,001 | 34,463 | 1,141,052 | 1.1 M to 1.1 M (+0.80 %) |
May 11 2021 | IVOB | INVO Bioscience, I ... | AWM Investment Company, Inc. | 10% Owner | Buy | P | 3.85 | 322 | 1,239 | 1,132,051 | 1.1 M to 1.1 M (+0.03 %) |
May 11 2021 | IVOB | INVO Bioscience, I ... | AWM Investment Company, Inc. | 10% Owner | Buy | P | 3.95 | 17,152 | 67,704 | 1,131,729 | 1.1 M to 1.1 M (+1.54 %) |
May 11 2021 | IVOB | INVO Bioscience, I ... | AWM Investment Company, Inc. | 10% Owner | Buy | P | 3.97 | 5,800 | 23,040 | 1,114,577 | 1.1 M to 1.1 M (+0.52 %) |
May 11 2021 | IVOB | INVO Bioscience, I ... | AWM Investment Company, Inc. | 10% Owner | Buy | P | 4.00 | 13,146 | 52,588 | 1,108,777 | 1.1 M to 1.1 M (+1.20 %) |
May 11 2021 | IVOB | INVO Bioscience, I ... | AWM Investment Company, Inc. | 10% Owner | Buy | P | 4.08 | 27,811 | 113,472 | 1,095,631 | 1.1 M to 1.1 M (+2.60 %) |
May 11 2021 | IVOB | INVO Bioscience, I ... | AWM Investment Company, Inc. | 10% Owner | Buy | P | 4.08 | 15,000 | 61,257 | 1,067,820 | 1.1 M to 1.1 M (+1.42 %) |
Jan 05 2021 | IVOB | INVO Bioscience, I ... | Szot Matthew K | Director | Option Exercise | A | 3.06 | 16,202 | 49,497 | 16,202 | |
Jan 05 2021 | IVOB | INVO Bioscience, I ... | Szot Matthew K | Director | Grant | A | 0.00 | 12,112 | 0 | 14,451 | 2.3 K to 14.5 K (+517.83 %) |
Jan 05 2021 | IVOB | INVO Bioscience, I ... | Shum Steve | Chief Executive Off ... | Option Exercise | A | 3.06 | 180,000 | 549,900 | 180,000 | |
Jan 05 2021 | IVOB | INVO Bioscience, I ... | Segal Jeffrey | Director | Option Exercise | A | 3.06 | 11,823 | 36,119 | 11,823 | |
Jan 05 2021 | IVOB | INVO Bioscience, I ... | Segal Jeffrey | Director | Grant | A | 0.00 | 8,838 | 0 | 9,975 | 1.1 K to 10 K (+777.31 %) |
Jan 05 2021 | IVOB | INVO Bioscience, I ... | Ryan Barbara | Director | Option Exercise | A | 3.06 | 13,574 | 41,469 | 13,574 | |
Jan 05 2021 | IVOB | INVO Bioscience, I ... | Ryan Barbara | Director | Grant | A | 0.00 | 10,148 | 0 | 12,465 | 2.3 K to 12.5 K (+437.98 %) |
Jan 05 2021 | IVOB | INVO Bioscience, I ... | Doody Kevin | Medical Director | Option Exercise | A | 3.06 | 10,947 | 33,443 | 10,947 | |
Jan 05 2021 | IVOB | INVO Bioscience, I ... | Doody Kevin | Medical Director | Grant | A | 0.00 | 8,184 | 0 | 169,821 | 161.6 K to 169.8 K (+5.06 %) |
Jan 05 2021 | IVOB | INVO Bioscience, I ... | DAVIS TRENT D | Director | Option Exercise | A | 3.06 | 14,012 | 42,807 | 14,012 | |
Jan 05 2021 | IVOB | INVO Bioscience, I ... | DAVIS TRENT D | Director | Grant | A | 0.00 | 10,475 | 0 | 13,573 | 3.1 K to 13.6 K (+338.12 %) |
Jan 05 2021 | IVOB | INVO Bioscience, I ... | Campbell Michael Jos. | Chief Operating Off ... | Option Exercise | A | 3.06 | 165,000 | 504,075 | 165,000 | |
Dec 01 2020 | IVOB | INVO Bioscience, I ... | Szot Matthew K | Director | Option Exercise | A | 3.19 | 2,339 | 7,467 | 2,339 | |
Dec 01 2020 | IVOB | INVO Bioscience, I ... | Szot Matthew K | Director | Grant | A | 0.00 | 2,339 | 0 | 2,339 | 0 to 2.3 K |
Dec 01 2020 | IVOB | INVO Bioscience, I ... | Segal Jeffrey | Director | Option Exercise | A | 3.19 | 1,137 | 3,630 | 1,137 | |
Dec 01 2020 | IVOB | INVO Bioscience, I ... | Segal Jeffrey | Director | Grant | A | 0.00 | 1,137 | 0 | 1,137 | 0 to 1.1 K |
Dec 01 2020 | IVOB | INVO Bioscience, I ... | Ryan Barbara | Director | Option Exercise | A | 3.19 | 2,317 | 7,397 | 2,317 | |
Dec 01 2020 | IVOB | INVO Bioscience, I ... | Ryan Barbara | Director | Grant | A | 0.00 | 2,317 | 0 | 2,317 | 0 to 2.3 K |
Feb 07 2020 | IVOB | INVO Bioscience, I ... | Karloff Kathleen t | Director | Option Exercise | A | 0.25 | 99,112 | 24,996 | 99,112 | |
Feb 07 2020 | IVOB | INVO Bioscience, I ... | Shum Steve | Chief Executive Off ... | Option Exercise | A | 0.25 | 99,112 | 24,996 | 99,112 | |
Feb 07 2020 | IVOB | INVO Bioscience, I ... | Doody Kevin | Medical Director | Option Exercise | A | 0.00 | 99,112 | 0 | 99,112 | |
Feb 07 2020 | IVOB | INVO Bioscience, I ... | Doody Kevin | Medical Director | Option Exercise | A | 0.25 | 99,112 | 24,996 | 99,112 | |
Feb 07 2020 | IVOB | INVO Bioscience, I ... | Campbell Michael Jos. | Chief Operating Off ... | Option Exercise | A | 0.25 | 99,112 | 24,996 | 99,112 | |
Feb 07 2020 | IVOB | INVO Bioscience, I ... | DAVIS TRENT D | Director | Option Exercise | A | 0.00 | 99,112 | 0 | 99,112 | |
Feb 07 2020 | IVOB | INVO Bioscience, I ... | DAVIS TRENT D | Director | Option Exercise | A | 0.25 | 99,112 | 24,996 | 99,112 | |
Jan 21 2020 | IVOB | INVO Bioscience, I ... | Campbell Michael Jos. | Chief Operating Off ... | Option Exercise | A | 0.21 | 4,000,000 | 855,200 | 4,000,000 | |
Jan 21 2020 | IVOB | INVO Bioscience, I ... | Campbell Michael Jos. | Chief Operating Off ... | Grant | A | 0.00 | 1,000,000 | 0 | 1,607,800 | 607.8 K to 1.6 M (+164.53 %) |
Oct 31 2019 | IVOB | INVO Bioscience, I ... | Bowdring Robert Joseph Jr | Director | Option Exercise | J | 0.29 | 875,050 | 252,889 | 875,050 | |
Oct 31 2019 | IVOB | INVO Bioscience, I ... | Karloff Kathleen t | Director | Option Exercise | J | 0.29 | 962,336 | 278,115 | 962,336 | |
Oct 31 2019 | IVOB | INVO Bioscience, I ... | Bowdring Robert Joseph Jr | Director | Option Exercise | J | 0.29 | 875,050 | 252,889 | 875,050 | |
Oct 31 2019 | IVOB | INVO Bioscience, I ... | Karloff Kathleen t | Director | Option Exercise | J | 0.29 | 962,336 | 278,115 | 962,336 | |
Oct 18 2019 | IVOB | INVO Bioscience, I ... | Shum Steve | Chief Executive Off ... | Option Exercise | A | 0.26 | 6,483,171 | 1,653,209 | 6,483,171 | |
Oct 18 2019 | IVOB | INVO Bioscience, I ... | Shum Steve | Chief Executive Off ... | Option Exercise | A | 0.26 | 6,483,171 | 1,653,209 | 6,483,171 | |
Oct 18 2019 | IVOB | INVO Bioscience, I ... | Shum Steve | Chief Executive Off ... | Grant | A | 0.00 | 400,000 | 0 | 1,000,000 | 600 K to 1000 K (+66.67 %) |
Oct 18 2019 | IVOB | INVO Bioscience, I ... | Shum Steve | Chief Executive Off ... | Grant | A | 0.00 | 400,000 | 0 | 1,000,000 | 600 K to 1000 K (+66.67 %) |
Dec 03 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.05 | 500,000 | 25,000 | 24,694,000 | 25.2 M to 24.7 M (-1.98 %) |
Dec 03 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | I | 0.00 | 1,000,000 | 100 | 25,194,000 | 26.2 M to 25.2 M (-3.82 %) |
Nov 02 2018 | IVOB | INVO Bioscience, I ... | Shum Steve | Director | Grant | A | 0.39 | 400,000 | 156,000 | 600,000 | 200 K to 600 K (+200.00 %) |
Nov 02 2018 | IVOB | INVO Bioscience, I ... | Karloff Kathleen t | Chairwoman and CEO | Grant | A | 0.39 | 1,040,183 | 405,671 | 13,200,183 | 12.2 M to 13.2 M (+8.55 %) |
Nov 02 2018 | IVOB | INVO Bioscience, I ... | Campbell Michael Jos. | Director | Grant | A | 0.39 | 400,000 | 156,000 | 607,800 | 207.8 K to 607.8 K (+192.49 %) |
Nov 02 2018 | IVOB | INVO Bioscience, I ... | Bowdring Robert Joseph Jr | Director | Grant | A | 0.39 | 1,015,942 | 396,217 | 11,715,942 | 10.7 M to 11.7 M (+9.49 %) |
Nov 01 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Grant | A | 0.39 | 910,878 | 355,242 | 26,194,000 | 25.3 M to 26.2 M (+3.60 %) |
Mar 07 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.19 | 12,642 | 2,402 | 25,283,122 | 25.3 M to 25.3 M (-0.05 %) |
Mar 07 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.12 | 1,000 | 120 | 25,295,764 | 25.3 M to 25.3 M (0.00 %) |
Mar 02 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.18 | 2,000 | 360 | 25,296,764 | 25.3 M to 25.3 M (-0.01 %) |
Feb 27 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.18 | 100 | 18 | 25,298,764 | 25.3 M to 25.3 M (0.00 %) |
Feb 22 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.12 | 12,400 | 1,488 | 25,298,864 | 25.3 M to 25.3 M (-0.05 %) |
Feb 22 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.12 | 17,900 | 2,148 | 25,311,264 | 25.3 M to 25.3 M (-0.07 %) |
Feb 22 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.11 | 5,000 | 570 | 25,329,164 | 25.3 M to 25.3 M (-0.02 %) |
Feb 22 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.11 | 10,000 | 1,120 | 25,334,164 | 25.3 M to 25.3 M (-0.04 %) |
Feb 22 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.11 | 28,662 | 3,193 | 25,344,164 | 25.4 M to 25.3 M (-0.11 %) |
Feb 22 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.11 | 25,000 | 2,700 | 25,372,826 | 25.4 M to 25.4 M (-0.10 %) |
Feb 22 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.11 | 23,260 | 2,559 | 25,397,826 | 25.4 M to 25.4 M (-0.09 %) |
Feb 22 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.11 | 100 | 11 | 25,421,086 | 25.4 M to 25.4 M (0.00 %) |
Feb 16 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.11 | 2,740 | 301 | 25,421,186 | 25.4 M to 25.4 M (-0.01 %) |
Feb 16 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.11 | 11,050 | 1,216 | 25,423,926 | 25.4 M to 25.4 M (-0.04 %) |
Feb 16 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.11 | 100 | 11 | 25,434,976 | 25.4 M to 25.4 M (0.00 %) |
Feb 13 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.11 | 11,808 | 1,299 | 25,435,076 | 25.4 M to 25.4 M (-0.05 %) |
Feb 13 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.12 | 1,000 | 115 | 25,446,884 | 25.4 M to 25.4 M (0.00 %) |
Feb 08 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.11 | 16,015 | 1,786 | 25,447,884 | 25.5 M to 25.4 M (-0.06 %) |
Feb 08 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.11 | 100 | 11 | 25,463,899 | 25.5 M to 25.5 M (0.00 %) |
Feb 02 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.12 | 8,000 | 928 | 25,463,999 | 25.5 M to 25.5 M (-0.03 %) |
Feb 02 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.12 | 1,100 | 128 | 25,471,999 | 25.5 M to 25.5 M (0.00 %) |
Feb 02 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.12 | 9,500 | 1,112 | 25,473,099 | 25.5 M to 25.5 M (-0.04 %) |
Feb 02 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.12 | 100 | 12 | 24,482,599 | 24.5 M to 24.5 M (0.00 %) |
Jan 31 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.12 | 31,319 | 3,602 | 25,482,699 | 25.5 M to 25.5 M (-0.12 %) |
Jan 29 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.12 | 2,100 | 250 | 25,514 | 27.6 K to 25.5 K (-7.60 %) |
Jan 24 2018 | IVOB | INVO Bioscience, I ... | Shum Steve | Director | Grant | A | 0.12 | 200,000 | 23,000 | 200,000 | 0 to 200 K |
Jan 24 2018 | IVOB | INVO Bioscience, I ... | Karloff Kathleen t | Chairwoman and CEO | Grant | A | 0.12 | 200,000 | 23,000 | 12,160,000 | 12 M to 12.2 M (+1.67 %) |
Jan 24 2018 | IVOB | INVO Bioscience, I ... | Campbell Michael Jos. | Director | Grant | A | 0.12 | 200,000 | 23,000 | 207,800 | 7.8 K to 207.8 K (+2,564.10 %) |
Jan 24 2018 | IVOB | INVO Bioscience, I ... | Bowdring Robert Joseph Jr | Director | Grant | A | 0.12 | 200,000 | 23,000 | 10,700,000 | 10.5 M to 10.7 M (+1.90 %) |
Jan 23 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.12 | 13,500 | 1,613 | 25,516,118 | 25.5 M to 25.5 M (-0.05 %) |
Jan 23 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.12 | 20,000 | 2,340 | 25,529,618 | 25.5 M to 25.5 M (-0.08 %) |
Jan 23 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.12 | 10,000 | 1,160 | 25,549,618 | 25.6 M to 25.5 M (-0.04 %) |
Jan 23 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.13 | 3,000 | 375 | 25,559,618 | 25.6 M to 25.6 M (-0.01 %) |
Jan 18 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.15 | 600 | 87 | 25,562,618 | 25.6 M to 25.6 M (0.00 %) |
Jan 12 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.15 | 7,445 | 1,080 | 25,563,218 | 25.6 M to 25.6 M (-0.03 %) |
Jan 12 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.15 | 5,100 | 765 | 25,570,663 | 25.6 M to 25.6 M (-0.02 %) |
Jan 09 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.14 | 30,000 | 4,320 | 25,575,763 | 25.6 M to 25.6 M (-0.12 %) |
Jan 09 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.13 | 20,000 | 2,500 | 26,605,763 | 26.6 M to 26.6 M (-0.08 %) |
Jan 09 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.12 | 50,000 | 6,000 | 25,625,763 | 25.7 M to 25.6 M (-0.19 %) |
Jan 05 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.05 | 500,000 | 25,000 | 25,675,763 | 26.2 M to 25.7 M (-1.91 %) |
Jan 04 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.15 | 2,134 | 312 | 26,175,763 | 26.2 M to 26.2 M (-0.01 %) |
Jan 04 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.15 | 100 | 15 | 26,177,897 | 26.2 M to 26.2 M (0.00 %) |
Jan 04 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.16 | 600 | 93 | 26,177,997 | 26.2 M to 26.2 M (0.00 %) |
Jan 02 2018 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.16 | 4,525 | 701 | 26,178,597 | 26.2 M to 26.2 M (-0.02 %) |
Dec 29 2017 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.17 | 10,000 | 1,650 | 26,183,122 | 26.2 M to 26.2 M (-0.04 %) |
Dec 28 2017 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.05 | 140,000 | 7,000 | 26,283,122 | 26.4 M to 26.3 M (-0.53 %) |
Dec 28 2017 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.30 | 50,000 | 15,000 | 26,423,122 | 26.5 M to 26.4 M (-0.19 %) |
Dec 28 2017 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | I | 0.00 | 500,000 | 50 | 26,473,122 | 27 M to 26.5 M (-1.85 %) |
Dec 28 2017 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.30 | 100,000 | 30,000 | 26,973,122 | 27.1 M to 27 M (-0.37 %) |
Dec 22 2017 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.17 | 10,000 | 1,720 | 26,193,122 | 26.2 M to 26.2 M (-0.04 %) |
Dec 18 2017 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.17 | 20,000 | 3,400 | 26,203,122 | 26.2 M to 26.2 M (-0.08 %) |
Dec 18 2017 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.17 | 10,000 | 1,720 | 26,223,122 | 26.2 M to 26.2 M (-0.04 %) |
Dec 13 2017 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.18 | 10,000 | 1,800 | 26,233,122 | 26.2 M to 26.2 M (-0.04 %) |
Dec 13 2017 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.18 | 20,000 | 3,562 | 26,243,122 | 26.3 M to 26.2 M (-0.08 %) |
Dec 13 2017 | IVOB | INVO Bioscience, I ... | Ranoux Claude | 10% Owner | Sell | S | 0.17 | 20,000 | 3,440 | 26,263,122 | 26.3 M to 26.3 M (-0.08 %) |
Jul 03 2017 | IVOB | INVO Bioscience, I ... | Karloff Kathleen t | CEO / Chairman | Sell | S | 0.15 | 400,000 | 60,000 | 11,760,000 | 12.2 M to 11.8 M (-3.29 %) |
Page: 1